Amplitude Healthcare Acquisition (Amplitude Healthcare Acquisition) GF Value : $0.00 (As of May. 07, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Amplitude Healthcare Acquisition GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-07), Amplitude Healthcare Acquisition's share price is $16.28. Amplitude Healthcare Acquisition's GF Value is $0.00. Therefore, Amplitude Healthcare Acquisition's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Amplitude Healthcare Acquisition is Not Valued.

Amplitude Healthcare Acquisition (NAS:AMHCU) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Amplitude Healthcare Acquisition's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	16.28	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amplitude Healthcare Acquisition GF Value Related Terms

Thank you for viewing the detailed overview of Amplitude Healthcare Acquisition's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplitude Healthcare Acquisition (Amplitude Healthcare Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Amplitude Healthcare Acquisition Corp (NAS:AMHCU) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

1177 Avenue of the Americas, Floor 40, New York, NY, USA, 10036

Website

Amplitude Healthcare Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Executives

Glazer Capital, Llc	10 percent owner	250 WEST 55TH STREET, SUITE 30A, NEW YORK NY 10019
Paul J Glazer	10 percent owner	250 WEST 55TH ST, SUITE 30A, NEW YORK NY 10019
Vishal Kapoor	officer: President	1177 AVENUE OF THE AMERICAS, FL 40, NEW YORK NY 10036
Balaji Venkataraman	director, 10 percent owner, officer: Chief Executive Officer	FIRST HORIZON PHARMACEUTICAL CORP, 660 HEMBREE PKWY STE 106, ROSWELL GA 30076
Howard I Hoffen	director, 10 percent owner	1585 BROADWAY, NEW YORK NY 10036
Kenneth F Clifford	10 percent owner, officer: Chief Financial Officer	1177 AVENUE OF THE AMERICAS, 40TH FLOOR, NEW YORK NY 10036
Amplitude Healthcare Holdings Llc	10 percent owner	1177 AVENUE OF THE AMERICAS, FLOOR 40, NEW YORK NY 10036
Peter R Dolan	director	C/O BRISTOL MYERS SQUIBB CO, 345 PARK AVE, NEW YORK NY 10164
Ernest Mario	director	20 FAIRMOUNT AVENUE, P.O. BOX 445, CHATHAM NJ 07928
Fredric N Eshelman	director	PPD INC, 929 NORTH FRONT STREET, WILMINGTON NC 28401
Glenn Reicin	director	1177 AVENUE OF THE AMERICAS, F140, NEW YORK NY 10036

Amplitude Healthcare Acquisition (Amplitude Healthcare Acquisition) Headlines

From GuruFocus

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Amplitude Healthcare Acquisition Corp. - AMHC

By PRNewswire PRNewswire • 06-08-2021

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation

By Business Wire Business Wire • 05-06-2021

Amplitude Healthcare Acquisition Corporation Announces Closing of $100,000,000 Initial Public Offering

By Marketwired Marketwired • 11-22-2019

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members

By Business Wire Business Wire • 09-20-2021

Amplitude Healthcare Acquisition Corporation Announces Pricing of $100,000,000 Initial Public Offering

By Marketwired Marketwired • 11-20-2019

Amplitude Healthcare Acquisition Corporation Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing January 10, 2020

By Marketwired Marketwired • 01-07-2020

Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.

By Marketwired Marketwired • 09-22-2021

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy

By Business Wire Business Wire • 09-24-2021